FILE:SIAL/SIAL-8K-20041110152125.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
Item 7.01. Regulation FD Disclosure
 
On November 9, 2004, Sigma-Aldrich Corporation issued a press release announcing the Company's quarterly dividend. A copy of this press release is furnished with this report as an exhibit to this Form 8-K and incorporated by reference herein.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: November 10, 2004
 
 

Exhibit 99.1
 
 
 
 
November 9, 2004
 
 
At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.17 per share. The dividend is payable on December 15, 2004 to shareholders of record on December 1, 2004.
 
: Sigma-Aldrich is a leading and company. Our biochemical and organic chemical products, kits and services are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 34 countries and has over 6,000 employees providing excellent service worldwide. We are committed to the success of our Customers, Employees and Shareholders through leadership in , and . For more information about Sigma-Aldrich, please visit our award-winning web site at www.sigma-aldrich.com
About Sigma-Aldrich
Life Science
High Technology
Life Science
High Technology
Service


